Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adjunctive Treatment in Major Depressive Di
HLP003 achieved statistically significant and clinically meaningful results in the primary and key s
HLP003 achieved statistically significant and clinically meaningful results in the primary and key s